Restless Leg Syndrome Diagnosis and Treatment
Restless Leg Syndrome (RLS) is diagnosed based on five essential criteria established by the International Restless Legs Syndrome Study Group, and first-line treatment includes dopamine agonists such as ropinirole or alpha2-delta calcium channel ligands, with iron supplementation when indicated. 1
Diagnostic Criteria for RLS
All five of the following essential criteria must be met for diagnosis:
- An urge to move the legs, usually accompanied by uncomfortable and unpleasant sensations in the legs
- The urge to move and accompanying sensations begin or worsen during periods of rest or inactivity
- The urge to move and accompanying sensations are partially or totally relieved by movement (walking, stretching) as long as the activity continues
- The urge to move and accompanying sensations are worse in the evening or night compared to daytime
- The symptoms are not solely accounted for by another medical or behavioral condition (RLS mimics)
Clinical Significance Specifier
Symptoms must cause significant distress or impairment in social, occupational, educational or other important areas of functioning through their impact on:
- Sleep
- Energy/vitality
- Daily activities
- Behavior
- Cognition
- Mood
Clinical Course Specifiers
- Chronic-persistent RLS: Symptoms occur at least twice weekly for the past year when untreated
- Intermittent RLS: Symptoms occur less than twice weekly for the past year, with at least 5 lifetime events
Differential Diagnosis - RLS Mimics
It's critical to rule out conditions that can mimic RLS 1:
- Leg cramps
- Venous stasis
- Leg edema
- Arthritis
- Positional discomfort
- Habitual foot tapping
- Myalgia
- Neuropathy
Diagnostic Approach
Clinical interview focusing on the five essential criteria
Evaluate for secondary causes:
- Iron deficiency (check serum ferritin)
- Pregnancy
- Renal failure
- Neuropathy
- Essential tremor
- Genetic ataxias
Consider sleep study if periodic limb movements during sleep are suspected (present in most RLS patients but not required for diagnosis)
Treatment Options
First-Line Treatments
Dopamine Agonists 2:
- Ropinirole: Start at 0.25 mg once daily 1-3 hours before bedtime, titrate based on response over 7 weeks to maximum 4 mg daily
- Clinical trials showed significant improvement in RLS symptoms with ropinirole compared to placebo as measured by the International RLS Rating Scale (IRLS)
Alpha2-Delta Calcium Channel Ligands 3:
- Gabapentin
- Pregabalin
- Gabapentin enacarbil
Iron Supplementation 3:
- For patients with low or low-normal serum ferritin
- Can be oral or IV depending on severity and response
Second-Line Treatments
Opioids 4:
- Used when first-line treatments fail or are contraindicated
Benzodiazepines 4:
- Generally considered third-line due to side effect profile
Treatment Considerations and Pitfalls
Augmentation
A major pitfall with dopaminergic treatment is augmentation - paradoxical worsening of symptoms with long-term use 3:
- Characterized by earlier symptom onset
- Increased symptom severity
- Anatomic spread of symptoms
Management of augmentation:
- Add an alpha2-delta ligand or opioid
- Once adequate symptom control is achieved, very slowly taper the dopamine agonist
Secondary RLS
Always treat underlying conditions 5:
- Iron supplementation for iron deficiency
- Address medications that may worsen RLS (antidepressants, antihistamines)
- Treat comorbid sleep disorders like OSA
Monitoring and Follow-up
Assess treatment response using validated tools:
- International RLS Rating Scale (IRLS)
- Clinical Global Impression-Global Improvement (CGI-I)
Monitor for side effects:
Watch for augmentation with dopaminergic agents
Reassess iron status periodically in patients with initial iron deficiency
By following these diagnostic criteria and treatment approaches, most patients with RLS can achieve significant symptom relief and improved quality of life.